6090 — Human Metabolome Technologies Balance Sheet
0.000.00%
- ¥4bn
- ¥3bn
- ¥1bn
- 43
- 46
- 77
- 59
Annual balance sheet for Human Metabolome Technologies, fiscal year end - June 30th, JPY millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1,219 | 1,245 | 1,505 | 1,657 | 1,789 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 65 | 149 | 158 | 130 | 228 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,411 | 1,457 | 1,742 | 1,848 | 2,096 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 108 | 127 | 243 | 271 | 332 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,538 | 1,623 | 2,069 | 2,291 | 2,603 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 300 | 317 | 546 | 493 | 633 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 323 | 363 | 582 | 519 | 657 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1,215 | 1,260 | 1,487 | 1,772 | 1,947 |
Total Liabilities & Shareholders' Equity | 1,538 | 1,623 | 2,069 | 2,291 | 2,603 |
Total Common Shares Outstanding |